27-Hydroxycholesterol contributes to disruptive effects on learning and memory by modulating cholesterol metabolism in the rat brain

Neuroscience

Volumn 300, Issue , 2015, Pages 163-173

  Zhang, D D ^a   Yu, H L ^a   Ma, W W ^a   Liu, Q R ^a   Han, J ^a   Wang, H ^a   Xiao, R ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

27 hydroxycholesterol; ABCA1; Cholesterol metabolism; Cognitive; HMG CR; LXR

Indexed keywords

26 HYDROXYCHOLESTEROL; ABC TRANSPORTER A1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LIVER X RECEPTOR ALPHA; LOW DENSITY LIPOPROTEIN RECEPTOR; 27-HYDROXYCHOLESTEROL; ANTILIPEMIC AGENT; CHOLESTEROL; CHOLESTEROL DERIVATIVE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN LEVEL; BRAIN METABOLISM; BRAIN TISSUE; CHOLESTEROL METABOLISM; COGNITION; CONTROLLED STUDY; LEARNING; MALE; MEMORY; NONHUMAN; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TAIL VEIN; ANIMAL; BRAIN; DOSE RESPONSE; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SPATIAL LEARNING; SPATIAL MEMORY; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN; CHOLESTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYDROXYCHOLESTEROLS; HYPERCHOLESTEROLEMIA; HYPOLIPIDEMIC AGENTS; IMMUNOHISTOCHEMISTRY; MALE; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPATIAL LEARNING; SPATIAL MEMORY;

EID: 84930644308     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.05.022     Document Type: Article

References (37)

1. Agarwal-Mawal A., Murray C.M., Belkhode S., Cheema S.K. Differential regulation of cholesterol homeostasis in transgenic mice expressing human cholesterol ester transfer protein. Can J Physiol Pharmacol 2007, 85:430-438.
2. Ali Z., Heverin M., Olin M., Acimovic J., Lövgren-Sandblom A., Shafaati M., Båvner A., Meiner V., Leitersdorf E., Björkhem I. On the regulatory role of side-chain hydroxylated oxysterols in the brain. Lessons from CYP27A1 transgenic and Cyp27a1(-/-) mice. J Lipid Res 2013, 54:1033-1043.
3. Benarroch E.E. Brain cholesterol metabolism and neurologic disease. Neurology 2008, 71:1368-1373.
4. Bjorkhem I. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J Intern Med 2006, 260:493-508.
5. Brown A.J., Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 1999, 142:1-28.
6. Bruce C., Chouinard R.A., Tall A.R. Plasma lipid transfer proteins, high density lipoproteins, and reverse cholesterol transport. Annu Rev Nutr 1998, 18:297-330.
7. Celestino A.T., Levy D., Maria Ruiz J.L., Bydlowski S.P. ABCB1, ABCC1, and LRP gene expressions are altered by LDL, HDL, and serum deprivation in a human doxorubicin-resistant uterine sarcoma cell line. Biochem Biophys Res Commun 2015, 457:664-668.
8. Chawla A., Boisvert W.A., Lee C.H., Laffitte B.A., Barak Y., Joseph S.B., Liao D., Nagy L., Edwards P.A., Curtiss L.K., Evans R.M., Tontonoz P. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell 2001, 7:161-171.
9. Dasari B., Prasanthi J.R., Meiers C., Singh B.B., Ghribi O. Differential effects of the estrogen receptor agonist estradiol on toxicity induced by enzymatically-derived or autoxidation- derived oxysterols in human ARPE-19 cells. Curr Eye Res 2013, 38:1159-1171.
10. Gamba P., Guglielmotto M., Testa G., Monteleone D., Zerbinati C., Gargiulo S., Biasi F., Iuliano L., Giaccone G., Mauro A., Poli G., Tamagno E., Leonarduzzi G. Upregulation of beta-amyloidogenesis in neuron-like human cells by both 24-and 27-hydroxycholesterol: protective effect of N-acetyl-cysteine. Aging Cell 2014, 13:561-572.
11. Gao J.L., Schneider E.H., Dimitrov E.L., Haun F., Pham T.M., Mohammed A.H., Usdin T.B., Murphy P.M. Reduced fear memory and anxiety-like behavior in mice lacking formylpeptide receptor 1. Behav Genet 2011, 41:724-733.
12. Goodrum J.F. Cholesterol from degenerating nerve myelin becomes associated with lipoproteins containing apolipoprotein E. J Neurochem 1991, 56:2082-2086.
13. Gordon D.A. Recent advances in elucidating the role of the microsomal triglyceride transfer protein in apolipoprotein B lipoprotein assembly. Curr Opin Lipidol 1997, 8:131-137.
14. Heverin M., Meaney S., Lutjohann D., Diczfalusy U., Wahren J., Björkhem I. Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain. J Lipid Res 2005, 46:1047-1052.
15. Heverin M., Maioli S., Pham T., Mateos L., Camporesi E., Ali Z., Winblad B., Cedazo-Minguez A., Björkhem I. 27-Hydroxycholesterol mediates negative effects of dietary cholesterol on cognition in mice. Behav Brain Res 2014, 278:356-359.
16. Hughes T.M., Rosano C., Evans R.W., Kuller L.H. Brain cholesterol metabolism, oxysterols, and dementia. J Alzheimers Dis 2013, 33:891-911.
17. Jansen D., Janssen C.I., Vanmierlo T., Dederen P.J., van Rooij D., Zinnhardt B., Nobelen C.L., Janssen A.L., Hafkemeijer A., Mutsaers M.P., Doedée A.M., Kuipers A.A., Broersen L.M., Mulder M., Kiliaan A.J. Cholesterol and synaptic compensatory mechanisms in Alzheimer's disease mice brain during aging. J Alzheimers Dis 2012, 31:813-826.
18. Kim H.J., Fan X., Gabbi C., Yakimchuk K., Parini P., Warner M., Gustafsson J.A. Liver X receptor beta (LXRbeta): a link between beta-sitosterol and amyotrophic lateral sclerosis-Parkinson's dementia. Proc Natl Acad Sci U S A 2008, 105:2094-2099.
19. Kim W.S., Chan S.L., Hill A.F., Guillemin G.J., Garner B. Impact of 27-hydroxycholesterol on amyloid-beta peptide production and ATP-binding cassette transporter expression in primary human neurons. J Alzheimers Dis 2009, 16:121-131.
20. Kivipelto M., Helkala E.L., Hänninen T., Laakso M.P., Hallikainen M., Alhainen K., Soininen H., Tuomilehto J., Nissinen A. Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology 2001, 56:1683-1689.
21. Lange Y., Ye J., Rigney M., Steck T.L. Regulation of endoplasmic reticulum cholesterol by plasma membrane cholesterol. J Lipid Res 1999, 40:2264-2270.
22. Lange Y., Ory D.S., Ye J., Lanier M.H., Hsu F.F., Steck T.L. Effectors of rapid homeostatic responses of endoplasmic reticulum cholesterol and 3-hydroxy-3-methylglutaryl-CoA reductase. J Biol Chem 2008, 283:1445-1455.
23. Lütjohann D., Breuer O., Ahlborg G., Nennesmo I., Sidén A., Diczfalusy U., Björkhem I. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci U S A 1996, 93:9799-9804.
24. Lütjohann D., Papassotiropoulos A., Björkhem I., Locatelli S., Bagli M., Oehring R.D., Schlegel U., Jessen F., Rao M.L., von Bergmann K., Heun R. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J Lipid Res 2000, 41:195-198.
25. Marwarha G., Ghribi O. Does the oxysterol 27-hydroxycholesterol underlie Alzheimer's disease-Parkinson's disease overlap?. Exp Gerontol 2014.
26. Marwarha G., Rhen T., Schommer T., Ghribi O. The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors-relevance to Parkinson's disease. J Neurochem 2011, 119:1119-1136.
27. Mateos L., Akterin S., Gil-Bea F.J., Spulber S., Rahman A., Björkhem I., Schultzberg M., Flores-Morales A., Cedazo-Mínguez A. Activity-regulated cytoskeleton-associated protein in rodent brain is down-regulated by high fat diet in vivo and by 27-hydroxycholesterol in vitro. Brain Pathol 2009, 19:69-80.
28. Oliveira H.C., Chouinard R.A., Agellon L.B., Bruce C., Ma L., Walsh A., Breslow J.L., Tall A.R. Human cholesteryl ester transfer protein gene proximal promoter contains dietary cholesterol positive responsive elements and mediates expression in small intestine and periphery while predominant liver and spleen expression is controlled by 5'-distal sequences. Cis-acting sequences mapped in transgenic mice. J Biol Chem 1996, 271:31831-31838.
29. Park S.H., Kim J.H., Choi K.H., Jang Y.J., Bae S.S., Choi B.T., Shin H.K. Hypercholesterolemia accelerates amyloid β-induced cognitive deficits. Int J Mol Med 2013, 31:577-582.
30. Peet D.J., Turley S.D., Ma W., Janowski B.A., Lobaccaro J.M., Hammer R.E., Mangelsdorf D.J. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 1998, 93:693-704.
31. Popp J., Lewczuk P., Kölsch H., Meichsner S., Maier W., Kornhuber J., Jessen F., Lütjohann D. Cholesterol metabolism is associated with soluble amyloid precursor protein production in Alzheimer's disease. J Neurochem 2012, 123:310-316.
32. Prasanthi J.R., Larson T., Schommer J., Ghribi O. Silencing GADD153/CHOP gene expression protects against Alzheimer's disease-like pathology induced by 27-hydroxycholesterol in rabbit hippocampus. PLoS One 2011, 6:e26420.
33. Shafaati M., Marutle A., Pettersson H., Lövgren-Sandblom A., Olin M., Pikuleva I., Winblad B., Nordberg A., Björkhem I. Marked accumulation of 27-hydroxycholesterol in the brain of patients with the Swedish APP 670/671 mutation. J Lipid Res 2011, 52:1004-1010.
34. Shobab L.A., Hsiung G.Y., Feldman H.H. Cholesterol in Alzheimer's disease. Lancet Neurol 2005, 4:841-852.
35. Sjögren M., Mielke M., Gustafson D., Zandi P., Skoog I. Cholesterol and Alzheimer's disease-is there a relation?. Mech Ageing Dev 2006, 127:138-147.
36. Thirumangalakudi L., Prakasam A., Zhang R., Bimonte-Nelson H., Sambamurti K., Kindy M.S., Bhat N.R. High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice. J Neurochem 2008, 106:475-485.
37. Thomas J., Shentu T.P., Singh Dev K. Cholesterol: biosynthesis, functional diversity, homeostasis and regulation by natural products. InTech Open 2012, 18:419-442.